The Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022
Made: 17th May 2022
Laid before Parliament: 23rd May 2022
Coming into force: 14th June 2022
In accordance with section 31(3) of that Act the Secretary of State has consulted the Advisory Council on the Misuse of Drugs.
Citation, Commencement and Extent
1
- (1) These Regulations may be cited as the Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022 and come into force on 14th June 2022.
- (2) These Regulations extend to England and Wales and Scotland.
Revocation of the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021
2
The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021[^f00002] are revoked.
Signed
Kit Malthouse — Minister of State — Home Office — 17th May 2022
Explanatory note
(This note is not part of the Regulations)
EXPLANATORY NOTE
These Regulations revoke the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021 (S.I. 2021/1427) (“the 2021 Regulations”).
The 2021 Regulations removed regulation 4B of the Misuse of Drugs Regulations 2001 (“the 2001 Regulations”), that made it lawful to import, export, produce, supply, offer to supply or possess Gamma–butyrolactone (GBL) and 1,4–Butanediol (1,4-BD) in certain circumstances. The 2021 Regulations also added 1,4-Butanediol (1,4-BD) and Gamma-butyrolactone (GBL) to Schedule 1 to the 2001 Regulations. The Schedule in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the 2001 Regulations are those subject to the tightest controls, requiring a Home Office licence in order to access such drugs.
Revocation of the 2021 Regulations means that the exemption in regulation 4B of the 2001 Regulations will remain in force and 1,4-Butanediol (1,4-BD) and Gamma-butyrolactone (GBL) will not be placed in Schedule 1, so a Home Office controlled drugs licence will not be required to lawfully import, export, produce, supply or possess these drugs.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen.
Footnotes
[^f00001]: 1971 c. 38. Section 22 was amended by the Police Reform and Social Responsibility Act 2011 (c. 13), Schedule 17, paragraph 14. See the definition of “prescribed” in section 37(1).
[^f00002]: S.I. 2021/1427.
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.